MarketInOut Stock Screener Log In | Sign Up

Heron Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026 16:00
Heron Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization57.24 mln
Float188 mln
Earnings Date11/09/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-2.79
Likely reliable

Relative Strength

8 / 100
Severely lagging

Debt / Equity

21.48
Extremely leveraged

Pre-Tax Margin

-23%
Deeply loss-making

ROE

-946
Deeply negative

Business Description

Heron Therapeutics is a North Carolina-based biotech company focused on improving patient care through innovative drug delivery. Its core technology allows a single dose of medication to remain active in the body for days or even weeks, reducing how often patients need treatment. The company sells several approved products that help cancer patients manage nausea and vomiting caused by chemotherapy, and it is also developing a local anesthetic designed to provide longer-lasting pain relief after surgery.

Key Fundamentals

EPS-0.18
ROE-946
RPS0.82
ROIC-4.82
ROA-10.32
Interest Cover-2.79
EBITDA, mln-23.41
EV / EBITDA-7.12
EV / EBIT-6.52
Revenue, mln151
EV / Revenue1.10

Quote Details

Last 0.3089
Change 0.0074 (2.45%)
Open 0.30
Volume 697,658
Turnover 215,507
Average Volume 2,279,573

Financial Ratios

Pre-Tax Profit Margin-23
Leverage Ratio36.52
Current Ratio2.49
Price / Book10.45
Price / Tangible Book10.45
Debt / Equity21.48
Price / Sales0.39

Financial Strength

Altman Z-Score-9.78
Piotroski F-Score 2 / 9
Beneish M-Score-2.79
Short Ratio21.32
Short % of Float30.88

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.83% 9 / 100   
1 Month 0.95% 68 / 100   
2 Months -32.7% 14 / 100   
6 Months -74.04% 5 / 100   
1 Year -73.82% 11 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog